LIMA1 and hepatocellular carcinoma: Given that, we first treated HCC cells with MG132, a regent for ubiquitination inhibition, and observed that the decreased BMI1 level was greatly reversed in the LIMA1 knockdown or overexpression group (Figure 4E).